| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Thermopylae Holdings Ltd. is 10% Owner at ABCL.
Historically, Thermopylae Holdings Ltd.'s trades have earned a middling insider score of 64/100 across 14 rated trades. Over a 12-month horizon, 25.0% of those trades were profitable, with an average 12-month return of -2.3%.
The ABCL filings lean toward selling, a net 2,277,653 shares.
Thermopylae Holdings Ltd. has 17 Form 4 filings on record from June 2021 to February 2026, all as 10% Owner at AbCellera Biologics (ABCL), 2021–2026.
The 18 reported transactions were 13 open-market purchases, 4 gifts and 1 open-market sale.
Counted by filing, the open-market trades come to 12 purchases worth about $21.5M and 1 sale worth about $134.5M.
The largest open-market purchase was 1,408,468 shares of ABCL at an average $6.41 on May 12, 2022, about $9.0M. Twelve months later ABCL was down 14%.
The only open-market sale was 5,598,420 shares of ABCL at an average $24.03 on June 9, 2021, about $134.5M. Twelve months later ABCL was down 65%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | ABCL Abcellera Biologics Inc. | 10% Owner | Buy | 38,000 | $3.44 | $130,720.00 | - | +59.2% | - | |
| Feb 26, 2026 | ABCL Abcellera Biologics Inc. | 10% Owner | Buy | 177,457 | $3.27 | $580,284.39 | +0.3% | +51.3% | - | |
| Mar 11, 2025 | ABCL Abcellera Biologics Inc. | 10% Owner | Buy | 343,631 | $2.16 | $742,242.96 | +0.6% | +12.6% | +63.7% | |
| Aug 29, 2024 | ABCL Abcellera Biologics Inc. | 10% Owner | Buy | 283,516 | $2.61 | $739,976.76 | +0.5% | +18.6% | +65.2% | |
| May 26, 2023 | ABCL Abcellera Biologics Inc. | 10% Owner | Buy | 153,000 | $6.52 | $997,728.30 | +0.3% | -19.1% | -43.4% | |
| Dec 16, 2022 | ABCL Abcellera Biologics Inc. | 10% Owner | Buy | 85,102 | $10.10 | $859,249.36 | +0.2% | -26.7% | -46.8% | |
| Aug 19, 2022 | ABCL Abcellera Biologics Inc. | 10% Owner | Buy | 200,000 | $11.46 | $2,292,460.00 | +0.4% | +23.1% | -52.0% | |
| Jun 14, 2022 | ABCL Abcellera Biologics Inc. | 10% Owner | Buy | 64,088 | $8.03 | $514,908.03 | +0.1% | +25.9% | -16.0% | |
| Jun 6, 2022 | ABCL Abcellera Biologics Inc. | 10% Owner | Buy | 64,545 | $7.50 | $483,964.86 | +0.1% | +36.4% | -9.9% | |
| May 13, 2022 | ABCL Abcellera Biologics Inc. | 10% Owner | Buy | 300,000 | $7.26 | $2,176,530.00 | +0.5% | +84.8% | -20.6% |